Hot Medical Stocks For 2019

tags:MCFT,SNPS,Y,

Investment company Exane Asset Management buys DowDuPont Inc, T-Mobile US Inc, Catalent Inc, Braskem SA, TechnipFMC PLC, Philip Morris International Inc, UBS Group AG, Biomarin Pharmaceutical Inc, NXP Semiconductors NV, NxStage Medical Inc, sells AT&T Inc, PQ Group Holdings Inc, Gilead Sciences Inc, Verizon Communications Inc, Liberty Global PLC during the 3-months ended 2017-12-31, according to the most recent filings of the investment company, Exane Asset Management. As of 2017-12-31, Exane Asset Management owns 97 stocks with a total value of $322 million. These are the details of the buys and sells.

New Purchases: DWDP, CTLT, BAK, PM, RGC, LOGI, BGC, OXY, BG, VET, Added Positions: TMUS, FTI, UBS, BMRN, NXPI, NXTM, APD, AKRX, BIIB, TMO, Reduced Positions: GILD, VZ, CNHI, QGEN, BAC, BMY, TSU, ASH, TWX, DBVT, Sold Out: T, PQG, LBTYA, CF, OLN, UNVR, ALXN, MRK, PCAR, VWR,

For the details of Exane Asset Management's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Exane+Asset+Management

Hot Medical Stocks For 2019: MCBC Holdings, Inc.(MCFT)

Advisors' Opinion:

• [By Ethan Ryder]

  MCBC Holdings (NASDAQ:MCFT) shares reached a new 52-week high and low during trading on Wednesday . The company traded as low as $30.42 and last traded at $30.27, with a volume of 14269 shares changing hands. The stock had previously closed at $29.28.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on MCBC (MCFT)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Ethan Ryder]

  Shares of MCBC Holdings Inc (NASDAQ:MCFT) have received an average rating of “Buy” from the eight brokerages that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $28.08.

Hot Medical Stocks For 2019: Synopsys, Inc.(SNPS)

Advisors' Opinion:

• [By Logan Wallace]

  These are some of the news headlines that may have effected Accern Sentiment’s analysis:

  Get Synopsys alerts: Synopsys, Inc. (SNPS) Receives Average Rating of “Buy” from Brokerages (americanbankingnews.com) Free Research Report as Applied Materials' Revenues Grew 28.8%; Adjusted EPS Surged 54.4% (finance.yahoo.com) Synopsys IC Validator Certified by Samsung Foundry for 7nm Signoff Physical Verification (prnewswire.com) Synopsys Fusion Technology Enables Lower Power, Smaller Area, and Higher Performance on Samsung Foundry 7LPP Process with EUV (prnewswire.com) Synopsys Announces New Release of LucidShape Software for Automotive Lighting Design and Analysis (finance.yahoo.com)

  A number of equities analysts recently commented on SNPS shares. KeyCorp reaffirmed an “overweight” rating and set a $110.00 price target (up from $106.00) on shares of Synopsys in a research note on Thursday, February 22nd. Royal Bank of Canada reaffirmed a “buy” rating on shares of Synopsys in a research note on Friday, February 23rd. Zacks Investment Research cut shares of Synopsys from a “hold” rating to a “strong sell” rating in a research note on Monday, February 26th. BidaskClub cut shares of Synopsys from a “hold” rating to a “sell” rating in a research note on Tuesday, February 27th. Finally, ValuEngine raised shares of Synopsys from a “hold” rating to a “buy” rating in a research report on Thursday, April 12th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. Synopsys presently has an average rating of “Buy” and an average target price of $102.71.

• [By Motley Fool Transcribers]

  Synopsys Inc  (NASDAQ:SNPS)Q1 2019 Earnings Conference CallFeb. 20, 2019, 5:00 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Chris Lange]

  The S&P 500 stock posting the largest daily percentage gain ahead of the close was Synopsys, Inc. (NASDAQ: SNPS) which traded up over 6% at $100.70. The stock's 52-week range is $77.91 to $101.76. Volume was about 4 million compared to the daily average volume of nearly 1 million.

• [By Motley Fool Staff]

  Synopsys (NASDAQ:SNPS) Q2 2018 Earnings Conference CallMay. 23, 2018 5:00 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

Hot Medical Stocks For 2019: Alleghany Corporation(Y)

Advisors' Opinion:

• [By Max Byerly]

  Xact Kapitalforvaltning AB increased its stake in shares of Alleghany Co. (NYSE:Y) by 15.6% during the first quarter, HoldingsChannel reports. The firm owned 1,612 shares of the insurance provider’s stock after buying an additional 217 shares during the period. Xact Kapitalforvaltning AB’s holdings in Alleghany were worth $990,000 at the end of the most recent reporting period.

• [By Stephan Byrd]

  Alleghany Co. (NYSE:Y) has earned an average recommendation of “Buy” from the five brokerages that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $650.00.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Alleghany (Y)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com